Jensen Margaret E Valeur's Net Worth
$16.5 Million
Who is Jensen Margaret E Valeur?
Jensen Margaret E Valeur has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, and Retrophin, Inc..
SEC CIK
Jensen Margaret E Valeur's CIK is 0001123346
Past Insider Trading and Trends
2004 was Jensen Margaret E Valeur's most active year for acquiring shares with 2 total transactions. Jensen Margaret E Valeur's most active month to acquire stocks was the month of December. 2008 was Jensen Margaret E Valeur's most active year for disposing of shares, totalling 14 transactions. Jensen Margaret E Valeur's most active month to dispose stocks was the month of January. 2004 saw Jensen Margaret E Valeur paying a total of $1,808,025.00 for 31,500 shares, this is the most they've acquired in one year. In 2015 Jensen Margaret E Valeur cashed out on 50,000 shares for a total of $1,022,948.64, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
EVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
| -9.44% | -12.32K |
$6.83 | -$84,103.71 | 118.26K |
Scheduled
|
Feb 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| -11.81% | -12.49K |
$2.53 | -$31,604.70 | 93.24K |
Scheduled
|
Mar 1
| ||
Form 4
| -10.72% | -8.70K |
$2.52 | -$21,940.79 | 72.4K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
| -16.40% | -12.12K |
$3.43 | -$41,549.19 | 61.76K |
Scheduled
|
Mar 30
| ||
Form 4
| -17.27% | -8.46K |
$3.25 | -$27,492.06 | 40.55K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| -17.81% | -7.66K |
$5.02 | -$38,505.11 | 35.37K |
Scheduled
|
Feb 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +5.61% | 1.5K |
$55.15 | $82,725.00 | 28.24K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Retrophin, Inc. (TVTX) Snapshot price: $10.98
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 50K |
—
|
—
| 100K |
Feb 1
| |||
Form 4
| -50.00% | -50.00K |
$20.46 | -$1,022,948.64 | 50K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |